Interesting rumor, but I'm not sure we have heard the last of the PLpro anti-Coronavirus mice trials from the University of Arizona or the upcoming K1.1-LNP xenograft mice in vivo cancer trials in March 2023.
Nonetheless, the RS has clearly failed. Had the PPS stayed above $4 (or even $2) in 2022 I might have thought otherwise. If it gets back to $2-4+ in 2023 then I'll have different thoughts on this!
Working with an insider to what? If hed just focus on running a solid business he wouldn’t have to worry about an opinion board. That is exactly why this company sucks. Worried about shit that isn’t even a problem.